Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
<p>Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant energetics contributes to its pathogenesis, significant uncertainty remains regarding the determinants of the clinical phenotype. The central hypothesis underlying this thesis is that the cl...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Julkaistu: |
2015
|